These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines. Voskas D; Mader R; Lee J; Hurta RA Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918 [TBL] [Abstract][Full Text] [Related]
5. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931 [TBL] [Abstract][Full Text] [Related]
6. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines. Hurta RA; Wright JA J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612 [TBL] [Abstract][Full Text] [Related]
7. The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. Hölttä E; Sistonen L; Alitalo K J Biol Chem; 1988 Mar; 263(9):4500-7. PubMed ID: 3279036 [TBL] [Abstract][Full Text] [Related]
8. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Wang YC; Bachrach U Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation is not involved in the structural alterations of ornithine decarboxylase or total chromatin of c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts. Laitinen J; Saris P; Hölttä E J Cell Biochem; 1995 Apr; 57(4):670-9. PubMed ID: 7615652 [TBL] [Abstract][Full Text] [Related]
11. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1). Hurta RA; Lee J; Voskas D J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396 [TBL] [Abstract][Full Text] [Related]
15. Ornithine decarboxylase induction in transformation by H-Ras and RhoA. Shantz LM; Pegg AE Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886 [TBL] [Abstract][Full Text] [Related]
16. c-Myc induces the expression and activity of ornithine decarboxylase. Wagner AJ; Meyers C; Laimins LA; Hay N Cell Growth Differ; 1993 Nov; 4(11):879-83. PubMed ID: 8297793 [TBL] [Abstract][Full Text] [Related]
17. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor. Endo Y; Matsushima K; Onozaki K; Oppenheim JJ J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724 [TBL] [Abstract][Full Text] [Related]
18. [Ornithine decarboxylase and S-adenosylmethionine decarboxylase bi-antisense virus inhibit growth and invasion of esophageal cancer cell line Eca109]. Song X; Tian H; Liu XX; Zhang B; Li WJ; Xu J Ai Zheng; 2008 Nov; 27(11):1144-9. PubMed ID: 19000443 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice. Lan L; Trempus C; Gilmour SK Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of ornithine decarboxylase as a measure of chemosensitivity testing. Bachrach U Methods Mol Med; 2005; 110():197-211. PubMed ID: 15901937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]